Investec Bank Plc has filed a Form 8.5 disclosure under Rule 8.5 of the Takeover Code regarding share dealings in Advanced Medical Solutions Group Plc.
The disclosure confirms that Investec acted in its capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connection to the offer under the Takeover Code’s disclosure framework.
The dealings were undertaken on 4th August 2026, with the formal public disclosure filed on 5th August 2026 in accordance with regulatory requirements.
On the purchase side, Investec acquired 609,558 ordinary shares in Advanced Medical Solutions Group Plc, with prices ranging from a low of 279.75p to a high of 280.25p per unit.
On the sales side, a total of 685,425 ordinary shares were sold, with prices ranging between 280p and 280.5p per share during the same dealing session.
The volume of shares sold exceeded purchases during the session, with 685,425 shares sold compared to 609,558 shares bought across ordinary share transactions.
Investec confirmed that no cash-settled derivative transactions, stock-settled derivative transactions, or options were involved in the disclosed dealings.
The firm also confirmed that no indemnity arrangements, option agreements, or other formal or informal understandings relating to relevant securities were in place that could act as an inducement to deal or refrain from dealing.
Similarly, Investec stated there were no agreements or understandings relating to voting rights under any option or to the future acquisition or disposal of any relevant securities referenced by a derivative instrument.
The contact named in the disclosure is Abhishek Gawde, reachable by telephone in connection with the filing.
Public disclosures under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service, ensuring transparency around dealings during offer periods.
